๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Estrogen replacement therapy and tamoxifen are contraindicated in patients with endometrial stromal sarcoma

โœ Scribed by Olaf Reich; Sigrid Regauer


Book ID
113960599
Publisher
Elsevier Science
Year
2006
Tongue
English
Weight
59 KB
Volume
102
Category
Article
ISSN
0090-8258

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Uterine adenofibroma and endometrial str
โœ Kazumasa Hayasaka; Kazuo Morita; Tomoya Saitoh; Yoshiaki Tanaka ๐Ÿ“‚ Article ๐Ÿ“… 2006 ๐Ÿ› Elsevier Science ๐ŸŒ English โš– 328 KB

Tamoxifen therapy may result in a variety of endometrial proliferative lesions, including adenofibroma and endometrial stromal sarcoma (ESS). This report describes the MR findings of adenofibroma and ESS associated with tamoxifen therapy. When MRI demonstrates a uterine mass appearing as a heterogen